Puma Biotechnology Affirms FY2025 Sales Guidance of $212.000M-$222.000M vs $217.800M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Puma Biotechnology (NASDAQ:PBYI) affirms FY2025 sales outlook from $212.000 million-$222.000 million to $212.000 million-$222.000 million vs $217.800 million estimate.
Puma Biotechnology (NASDAQ:PBYI) affirms FY2025 sales outlook from $212.000 million-$222.000 million to $212.000 million-$222.000 million vs $217.800 million estimate.